Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OPK · against 454 other Healthcare companies of similar size
Ranked #317 of 455 · scores higher than 9% of peers
Bars: peers in each 10-point band of the valuation score139 peers with a valuation score of 0–9, including OPK · Click a bar to see the companies
Mainly because of its EBITDA yield, free cash flow yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | OPK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 445 reported | -4.1% | 1.5% | 29% | 30% | |
| EBITDA yieldHigher is better · 459 reported | -5.6% | 4.3% | 21% | 50% | |
| Free cash flow yieldHigher is better · 207 reported | -10.4% | -1.6% | 21% | 20% | |
| Book yieldHigher is better · 450 reported | 92.3% | 40.6% | 89% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 317 | 1.6B USD | 8 | 30 | |
| 317 | 749M USD | 8 | 39 | |
| 317 | 1.5B USD | 8 | 30 | |
| 317 | 643M USD | 8 | 31 | |
| 317 | 1.3B USD | 8 | 20 | |
| 317 | 994M USD | 8 | 39 | |
| 317 | 1.9B USD | 8 | 32 | |
| 317 | 2.4B USD | 8 | ||
| 317 | 1.1B USD | 8 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score